Business Description
Formosa Laboratories Inc
ISIN : TW0004746003
Total Employee Number:
480Description
Formosa Laboratories Inc is mainly engaged in the wholesale and manufacturing of active pharmaceutical ingredients, as well as ultraviolet absorbers. The company geographically operates in India, Taiwan, Netherlands, Switzerland, Germany, Japan, China, Canada, United States, and Others.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.69 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.47 | |||||
Debt-to-EBITDA | 3.33 | |||||
Interest Coverage | 23.97 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.72 | |||||
Beneish M-Score | -2.77 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.7 | |||||
3-Year EBITDA Growth Rate | 9.5 | |||||
3-Year EPS without NRI Growth Rate | 0.4 | |||||
3-Year FCF Growth Rate | 32.3 | |||||
3-Year Book Growth Rate | 0.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 76.41 | |||||
9-Day RSI | 67.81 | |||||
14-Day RSI | 61.96 | |||||
3-1 Month Momentum % | -4.32 | |||||
6-1 Month Momentum % | -8.75 | |||||
12-1 Month Momentum % | -21.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.91 | |||||
Quick Ratio | 1.32 | |||||
Cash Ratio | 0.86 | |||||
Days Inventory | 223.56 | |||||
Days Sales Outstanding | 76.87 | |||||
Days Payable | 32.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.44 | |||||
Dividend Payout Ratio | 0.84 | |||||
3-Year Dividend Growth Rate | 14.5 | |||||
Forward Dividend Yield % | 5.44 | |||||
5-Year Yield-on-Cost % | 5.51 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 9.5 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 41.89 | |||||
Operating Margin % | 16.37 | |||||
Net Margin % | 9.09 | |||||
EBITDA Margin % | 22.34 | |||||
FCF Margin % | 9.73 | |||||
OCF Margin % | 27.11 | |||||
ROE % | 5.78 | |||||
ROA % | 3.21 | |||||
ROIC % | 6.3 | |||||
3-Year ROIIC % | -76.93 | |||||
ROC (Joel Greenblatt) % | 6.84 | |||||
ROCE % | 4.83 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.14 | |||||
Forward PE Ratio | 10.38 | |||||
PE Ratio without NRI | 15.42 | |||||
Shiller PE Ratio | 14.17 | |||||
Price-to-Owner-Earnings | 8.33 | |||||
PS Ratio | 1.38 | |||||
PB Ratio | 0.87 | |||||
Price-to-Tangible-Book | 0.91 | |||||
Price-to-Free-Cash-Flow | 14.05 | |||||
Price-to-Operating-Cash-Flow | 5.06 | |||||
EV-to-EBIT | 16.18 | |||||
EV-to-EBITDA | 7.99 | |||||
EV-to-Revenue | 1.79 | |||||
EV-to-FCF | 18.15 | |||||
Price-to-GF-Value | 0.56 | |||||
Price-to-Projected-FCF | 1.09 | |||||
Price-to-Median-PS-Value | 0.64 | |||||
Price-to-Graham-Number | 0.79 | |||||
Earnings Yield (Greenblatt) % | 6.18 | |||||
FCF Yield % | 7.13 | |||||
Forward Rate of Return (Yacktman) % | -10.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Formosa Laboratories Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 4,851.357 | ||
| EPS (TTM) (NT$) | 3.64 | ||
| Beta | -0.0538 | ||
| 3-Year Sharpe Ratio | -0.7 | ||
| 3-Year Sortino Ratio | -0.89 | ||
| Volatility % | 15.34 | ||
| 14-Day RSI | 61.96 | ||
| 14-Day ATR (NT$) | 1.583127 | ||
| 20-Day SMA (NT$) | 52.495 | ||
| 12-1 Month Momentum % | -21.65 | ||
| 52-Week Range (NT$) | 50 - 72 | ||
| Shares Outstanding (Mil) | 120.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Formosa Laboratories Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Formosa Laboratories Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 3.000000 Cash Dividend | 2025-08-21 | 66.00 (+0.61%) | ||
| TWD 2.000000 Cash Dividend | 2024-08-13 | 95.70 (-0.31%) |
Show
Entries
Formosa Laboratories Inc Frequently Asked Questions
What is Formosa Laboratories Inc(TPE:4746)'s stock price today?
The current price of TPE:4746 is NT$55.10. The 52 week high of TPE:4746 is NT$72.00 and 52 week low is NT$50.00.
When is next earnings date of Formosa Laboratories Inc(TPE:4746)?
The next earnings date of Formosa Laboratories Inc(TPE:4746) is .
Does Formosa Laboratories Inc(TPE:4746) pay dividends? If so, how much?
The Dividend Yield %  of Formosa Laboratories Inc(TPE:4746) is 5.44% (As of Today), Highest Dividend Payout Ratio of Formosa Laboratories Inc(TPE:4746) was 2.54. The lowest was 0.38. And the median was 1.13. The  Forward Dividend Yield % of Formosa Laboratories Inc(TPE:4746) is 5.44%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Formosa Laboratories Completes the Acquisition of Synchem to Expand North American CDMO Footprint | 2024-06-03 |
Articles on Formosa Laboratories Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers